PMGC Holdings (ELAB) Payables (2022 - 2026)
PMGC Holdings' (ELAB) quarterly Payables came in at $2.0 million in Q2 2026, up 642.37% year-over-year from $271567.0 in Q2 2025, and down 36.27% quarter-over-quarter from $3.2 million in Q1 2026.
Analysis
PMGC Holdings (ELAB) Payables (2022 - 2026) Analysis & Trends
PMGC Holdings has disclosed Payables across 5 years of filings, most recently posting $2.0 million for Q2 2026.
- In Q2 2026, Payables rose 642.37% year-over-year to $2.0 million; the TTM figure through Jun 2026 stood at $2.0 million (up 642.37% YoY), while the FY2025 annual figure was $1.1 million, up 132.03% from the prior year.
- Payables came in at $2.0 million for Q2 2026 at PMGC Holdings, down from $3.2 million in the prior quarter.
- In the past five years, Payables ranged from a high of $1.2 billion in Q3 2023 to a low of $271567.0 in Q2 2025.
- Average Payables over 5 years is $95.2 million, with a median of $1.1 million recorded in 2025.
- Year-over-year, Payables tumbled 99.9% in 2024 and jumped 722.89% in 2026.
- Over 5 years, Payables stood at $313159.0 in 2022, then surged by 60.68% to $503172.0 in 2023, then slipped by 4.41% to $481001.0 in 2024, then jumped by 132.03% to $1.1 million in 2025, then soared by 80.64% to $2.0 million in 2026.
- Per Business Quant data, the three most recent Payables figures were $2.0 million in Q2 2026, $3.2 million in Q1 2026, and $1.1 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.09 Bn | 192.10 Bn | 7.24 Bn | 2.87 Bn |
| 2 | Gilead Sciences | 179.75 Bn | 176.57 Bn | 6.22 Bn | 674.00 Mn |
| 3 | Vertex Pharmaceuticals | 131.11 Bn | 123.26 Bn | 2.84 Bn | 429.50 Mn |
| 4 | Regeneron Pharmaceuticals | 81.77 Bn | 73.78 Bn | 3.93 Bn | 1.16 Bn |
| 5 | Argenx Se | 60.45 Bn | 55.27 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 53.60 Bn | 48.46 Bn | 52.00 Mn | 167.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.36 Bn | 30.06 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Biogen | 31.72 Bn | 30.44 Bn | 1.96 Bn | 403.90 Mn |
| 9 | Roivant Sciences | 29.09 Bn | 29.09 Bn | 1.16 Mn | 25.08 Mn |
| 10 | PMGC Holdings | 2.29 Mn | -16.50 Mn | 385,691.00 | 2.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.02 Mn |
| Mar 31, 2026 | 3.16 Mn |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 271,567.00 |
| Mar 31, 2025 | 384,418.00 |
| Dec 31, 2024 | 481,001.00 |
| Sep 30, 2024 | 1.26 Mn |
| Jun 30, 2024 | 1.25 Mn |
| Mar 31, 2024 | 623,041.00 |
| Dec 31, 2023 | 503,172.00 |
| Sep 30, 2023 | 1.23 Bn |
| Dec 31, 2022 | 313,159.00 |